ANBC INC (SYUP) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of ANBC INC $0.00, price $0.00, upside +0.0%, quality 53 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch ANBC INC for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range $0.0001 – $1.75 · fair‑value band $0.0003 – $0.0003 · the $0.0003 price screens below the $0.0003 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow ANBC in your weekly email
Every Wednesday you see whether ANBC is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China.
Show more
ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. ANBC, INC. was formerly known as Shanghai Yutong Pharma, Inc. and changed its name to ANBC, INC. in August 2016. The company was incorporated in 2003 and is based in Shanghai, China.
Stock analysis
ANBC INC (SYUP) currently trades at $0.0003, while our model-based Fair Value estimate is $0.0003, so the stock looks roughly fairly valued today (gap 0.0%).
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $0.0005 per share, and 8 of the 21 models we run sit above the $0.0003 price.
Bear case: the Economic Profit group reads lowest at $0.0001, and 13 of the 21 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.0003 (bear) to $0.0003 (bull), the price of $0.0003 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
ANBC INC reported revenue of $3.2M in FY2017 versus $312K in FY2006, a compound +23.4%/yr. Reported net income was $1.3M in FY2017.
Key figures
Market cap $23.9K · P/S ratio 0.47 · Net margin 41.1% · Return on equity −23.9% · Return on assets (EBIT) 40.2% · Operating margin 811% · Revenue growth (YoY) −96.0% · Free cash flow $746K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 200% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at 0%, SYUP screens cheaper than that median.
Fair Value models
Bear $0.0003Fair Value $0.0003Bull $0.0003
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.73/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+10.0%
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
’04
’05
’06
’15
’16
’17
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−93.2% (2004) → 42.8% (2017)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 585 stocks
Beats the industry median on 5/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score55 · Above median
Fair Value upside+0.0% · Above median
Profitability
Return on assets−1.5% · Bottom 25%
Net margin (TTM)41.1% · Top 25%
Growth and dividend
Revenue growth−96.0% · Bottom 25%
Balance sheet
Debt / equity0.11× · Above median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "ANBC INC Fair Value". https://www.fairvalue-calculator.com/stock/SYUP
Frequently asked questions
Is ANBC INC (SYUP) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0003 versus the last price from Sep 25, 2026 of $0.0003, about +0% upside (fairly valued).
What is the fair value of SYUP?
Our model-based fair value for ANBC INC is $0.0003 (as of Sep 27, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0003.
What is the quality score of SYUP?
ANBC INC has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ANBC INC (SYUP)?
Our model-based price target is the fair value of $0.0003 (as of Sep 27, 2026) from 21 valuation models. Cautious scenario $0.0003, optimistic scenario $0.0003. It is a calculation from audited fundamentals, not an analyst target.
What is the ANBC INC stock forecast for 2026?
Our models put fair value at $0.0003, about +0% upside versus the last price from Sep 25, 2026 of $0.0003 (fairly valued). Cautious scenario $0.0003, optimistic scenario $0.0003. The calculation is refreshed regularly with new filings.
What is the intrinsic value of ANBC INC (SYUP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ANBC INC it is $0.0003 per share (as of Sep 27, 2026), against a price of $0.0003. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is ANBC INC stock overvalued or undervalued in 2026?
As of Sep 27, 2026, SYUP trades below its calculated fair value: price $0.0003, fair value $0.0003, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SYUP?
No. The price is what the market pays today ($0.0003); the fair value is what the company's own numbers justify ($0.0003). For ANBC INC the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is ANBC INC worth?
The market values ANBC INC at about $23.9K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0003; our models calculate a fair value of $0.0003 per share.
What do the bullish and bearish scenarios say about SYUP?
Our models span a range for ANBC INC: cautious scenario $0.0003, base $0.0003, optimistic $0.0003 per share (as of Sep 27, 2026, price $0.0003). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of ANBC INC (SYUP)?
Balance-sheet figures for ANBC INC (as of Sep 27, 2026): return on equity −23.9%, debt of 0.11 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is SYUP from its 52-week high?
ANBC INC trades at $0.0003, at its 52-week high of $0.0003 and 200% above the low of $0.0001 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0003 is for.
Which stocks are comparable to ANBC INC?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ANBC INC stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0003, calculated fair value $0.0003 (+0%), Quality Score 53/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SYUP calculated?
We run ANBC INC through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0003, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. ANBC INC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ANBC INC (SYUP)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0003. Our model-based fair value is $0.0003, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ANBC INC right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0003 to $0.0003), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of ANBC INC
How large is the market capitalisation of ANBC INC (SYUP)?
The market capitalisation of ANBC INC is $23.9K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ANBC INC (SYUP)?
The price-to-sales ratio of ANBC INC is 0.47 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of ANBC INC (SYUP)?
The net margin of ANBC INC is 41.1% (fiscal year 2017). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of ANBC INC (SYUP)?
The return on equity (ROE) of ANBC INC is −23.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ANBC INC (SYUP)?
On an EBIT basis the return on assets of ANBC INC is 40.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ANBC INC (SYUP)?
The operating margin of ANBC INC is 811% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ANBC INC (SYUP)?
Revenue at ANBC INC is growing −96.0% versus a year earlier (3y avg +296%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does ANBC INC (SYUP) generate?
The free cash flow of ANBC INC is $746K (fiscal year 2017). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does ANBC INC (SYUP) hold?
ANBC INC holds more cash than debt, $78.9K net (fiscal year 2017). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch ANBC INC in the live analysis
One click puts ANBC INC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026